Want to join the conversation?
Drugmaker giant $LLY said that 1Q16 revenue growth was 8% on a constant currency or performance basis. Most of this performance growth was driven by volume. The company's new products Trulicity, Cyramza, Jardiance, Basaglar and Portrazza drove 5 percentage points of this volume growth.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!
$SGY is expected to achieve $6.17 price target in next year, with a minimum target of $3.00, due to the price increase of 27.85% to $6.29 during the last trading session.